Dapagliflozin as Monotherapy in Drug-Naive Asian Patients With Type 2 Diabetes Mellitus: A Randomized, Blinded, Prospective Phase III Study
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference43 articles.
1. A mass survey of diabetes mellitus in a population of 300,000 in 14 provinces and municipalities in China;Zhonghua Nei Ke Za Zhi,1981
2. Prevalence of diabetes among men and women in China;Yang;N Engl J Med,2010
3. Projected and observed diabetes epidemics in China and beyond;Zhao;Curr Cardiol Rep,2012
4. Genetic advances of type 2 diabetes in Chinese populations;Yu;J Diabetes,2012
5. Primacy of the 3B approach to control risk factors for cardiovascular disease among type 2 diabetes;Ji;Am J Med,2013
Cited by 143 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Influence of Dapagliflozin Dosing on Low‐Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta‐Analysis;The Journal of Clinical Pharmacology;2024-08
2. Effects of dapagliflozin on body weight in patients with type 2 diabetes mellitus: Evidence‑based practice;Experimental and Therapeutic Medicine;2024-02-28
3. Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition);AGING MEDICINE;2024-02
4. First-line treatment with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetic population at low risk of cardiovascular disease: a meta-analysis;Frontiers in Endocrinology;2024-01-29
5. Geroprotector drugs and exercise: friends or foes on healthy longevity?;BMC Biology;2023-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3